Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Loading Content...Please Wait!
Name Card
rp00358 picture

Professor Kwong, Yok Lam 鄺沃林

Professor: Chair of Haematology and Haematological Oncology
Chui Fook-Chuen Professorship in Molecular Medicine
Professor (Clinical)

StatusProject CodeProject TitleAmountFunding Year
AR170012Ex vivo of dendritic cell functions uner iron overload conditions in thalassaemia patients2860002015/2016
AR170037PTCL Study - PD-1 blockade with pembrolizumab in relapsed/refractory mature T-cell and NK-cell lymphomas51411332016/2017
HKU 774309MStudy of a novel role of Pin1 in regulating invasiveness and metastasis of hepatocellular carcinoma via Rho signaling10391702009/2010
HKU 7357/02MNeovascularization of ischemic myocardium by autologous bone marrow cells transplantation8160002002/2003
HKU 777107MPost-translational regulation of survivin by peptidy-proplyl-isomerase Pin1 in hepatocellular carcinoma7914662007/2008
HKU 773108MA study of the modulatory effects of p53 on Pin1-mediated tumor growth, invasion and metastasis in hepatocellular carcinoma12924472008/2009
-Application of DNA technology in genetic diseases and blood cancers11400001993/1994
-Translational research in blood cancers and stem cell transplantation11600001997/1998
-Management of leukaemia and lymphoma01979/1980
-Nasal T/NK-cell lymphoma: CT and MR imaging features of a new clinico-pathological entity: lethal midline granuloma reclassified01998/1999
-BCL-6 gene rearrangement and hypermutation in Hong Kong Chinese patients with lymphoma01994/1995
HKU 414/94MUse of polymerase chain reactions (PCR) to detect minimal residual disease (MRD) in patients with leukaemia and lymphoma of T-cell lineage6500001994/1995
-Molecular genetics of common cancers in Hong Kong141370001999/2000
HKU 7307/00MStudy of the mechanisms of vascular homeostasis in obstructive sleep apnoea6960002000/2001
HKU 7529/03MDevelopment of monoclonal antibodies against SARS-associated coronavirus: specific targeting for early diagnosis and future treatment7500002003/2004
203217Direct intramyocardial implantation of autologous bone marrow cells for enhancement of neovascularization in patients with "End-Staged" coronary artery disease14000002003/2004
HKU 7593/05MCharacterization of the interaction between Pin1 and HBx in human hepatocellular carcinoma11719142005/2006
HKU 766408M18F-FDG PET-CT in prognostication and response assessment of aggressive mature T-cell and NK-cell lymphomas9580272008/2009
08070552Detection of WU and KI polyomaviruses from patients with acute respiratory tract infections in Hong Kong7995442007/2008
208203Provision of free service for serum polyoma BK virus quantification to kidney transplant recipients in Hong Kong6927002008/2009
208207Direct endomyocardial injection of autologous bone marrow cells for treatment of patients with "end-stage" ischaemic heart failure19650002008/2009
SEG_HKU03Medical cyclotron for the production of radiopharmaceuticals for positron emission tomography imaging in an academic medical center100000002008/2009
210213Provision of free sorafenib for patients with refractory or relapsed acute myeloid leukemia to bridge them to curative bone marrow transplantation6000002010/2011
12111842Risk of Hepatitis B Reactivation after Hematopoietic Stem Cell Transplantation in Donors and Recipients with Prior HBV Exposure9519602012/2013
HKU 779813MExtending the therapeutic application of arsenic trioxide in acute myeloid leukaemia6928262013/2014
213211Use of Bortezomib during conditioning of autologous stem cell transplantation of international stage III myeloma7740002013/2014
17118914Mechanisms of leukaemic transformation from myelodysplastic syndromes (MDS) failing treatment with demethylating agents.8355462014/2015
207215Provision of free alemtuzumab (anti-CD52) to patients with chronic lymphocytic leukemia refractory to conventional chemotherapy6112882007/2008
2151211Determination of Prognosis in Patients with Myelofibrosis Using Novel Molecular Markers4480002015/2016
2161212Provision of obinutuzumab (anti-CD20 monoclonal antibody) to elderly and/or unfit patients with chronic lymphocytic leukaemia8880002016/2017
Loading Content...Please Wait!